↓ Skip to main content

Universal health coverage and COVID-19: recent developments and implications

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, February 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (56th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
112 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Universal health coverage and COVID-19: recent developments and implications
Published in
Journal of Pharmaceutical Policy and Practice, February 2021
DOI 10.1186/s40545-021-00306-x
Pubmed ID
Authors

Rabia Hussain, Sara Arif

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 112 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 12%
Student > Ph. D. Student 10 9%
Student > Bachelor 10 9%
Student > Postgraduate 7 6%
Lecturer 6 5%
Other 16 14%
Unknown 50 45%
Readers by discipline Count As %
Nursing and Health Professions 22 20%
Medicine and Dentistry 14 13%
Business, Management and Accounting 5 4%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Social Sciences 4 4%
Other 12 11%
Unknown 51 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 May 2021.
All research outputs
#12,910,718
of 23,274,744 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#198
of 421 outputs
Outputs of similar age
#219,319
of 513,539 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#17
of 29 outputs
Altmetric has tracked 23,274,744 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 421 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 513,539 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.